Monitoring Tumor Response to Antiangiogenic Sunitinib Therapy with 18F-Fluciclatide, an 18F-Labeled  V 3-Integrin and  V 5-Integrin Imaging Agent

Title
Monitoring Tumor Response to Antiangiogenic Sunitinib Therapy with 18F-Fluciclatide, an 18F-Labeled  V 3-Integrin and  V 5-Integrin Imaging Agent
Authors
Keywords
-
Journal
JOURNAL OF NUCLEAR MEDICINE
Volume 52, Issue 3, Pages 424-430
Publisher
Society of Nuclear Medicine
Online
2011-02-15
DOI
10.2967/jnumed.110.077479

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now